IP Library Granted Patent US 7,244,232
Granted Patent B2
US 7,244,232 · App. 10/131,361 · Granted Jul 17, 2007

Process for identifying cancerous and/or metastatic cells of a living organism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,232
App. No.
10/131,361
Granted
Jul 17, 2007
Kind
B2
Abstract

A process for identifying and treating cells in a living organism. The cells are labeled, circulated within the organism, detected with an implanted detector, and then either isolated or ablated.

Claims (16)

1. A process for identifying cancerous and/or metastatic cells of a living organism, comprising the steps of:

feeding a fluid stream comprising said cancerous and/or metastatic cells, to a first assembly comprising a reservoir, wherein said reservoir contains markers capable of labeling the cancerous and/or metastatic cells;

labeling at least a portion of said cells with said markers so as to produce labeled cells;

feeding said fluid stream comprising said labeled cells to a second assembly comprising a particle analyzer, wherein said particle analyzer comprises a stent, wherein a plurality of optical assemblies capable of emitting and detecting radiation are disposed on the inner surface of said stent; then

detecting said labeled cancerous and/or metastatic cells with said particle analyzer.

2. The process as recited in claim 1 further comprising the step of estimating the positions of said labeled cells in or downstream from the stent by means of a three-dimensional, multivariate particle velocity and location estimation algorithm.

3. The process as recited in claim 1 , wherein said particle analyzer further comprises a flow cytometer.

4. The process as recited in claim 1 , further comprising the step of stripping said markers from the labeled cells within the fluid stream after exiting the particle analyzer, so as to produce a purified fluid stream.

5. The process as recited in claim 1 , wherein said marker is a non-toxic fluorescent marker.

6. The process as recited in claim 5 , wherein said marker is green fluorescent protein.

7. The process as recited in claim 1 , wherein said first and second assemblies are implanted within said living organism.

8. A process for identifying and treating cancerous and/or metastatic cells of a living organism, comprising conducting the process of claim 1 , and further comprising ablating said labeled cells, which have been detected by the particle analyzer, with an ablation device.

9. The process as recited in claim 8 , wherein the ablation device is positioned downstream from the particle analyzer.

10. The process as recited in claim 9 , wherein the distance between the particle analyzer and the ablation device is from about 100 microns to 2 millimeters.

11. The process of claim 8 , wherein the ablation device is a part of the stent of the particle analyzer.

12. The process as recited in claim 8 , wherein the ablation device comprises a plurality of lasers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2002
From: CONNELLY, PATRICK R.; FOSTER, THOMAS H.; WEINER, MICHAEL L.; CUSTER, ANDREW W.
To: BIOMED SOLUTIONS, LLC
Reel/Frame 013151/0149 →